PAR
NSEPar Drugs And Chemicals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹86.68
0.83 (0.97%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹107 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
8.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹78.05+11.1%
52W High₹122.43-29.2%
Current Price
₹86.68
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹69.34
Upper Circuit₹104.02
Reference Price
₹86.68
Investment Checklist
Head and Shoulders on 1W (BREAKOUT CONFIRMED) — target ₹55.77
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹79.38
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -55.07 (STRONG_SELL) with 86.6% confidence
10/20 Bearish Cross detected 3 day(s) ago
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
87%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
88.02
EMA50
89.1
EMA200
93.84
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows4
Lower Highs6
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹88.60
₹90.81
₹92.54
₹95.79
₹98.52
Support (Below)
₹84.00
₹82.80
₹81.00
₹78.05
Volume Analysis
TrendDECREASING
Change-63.40%
Unusual VolumeNo
Recent MA Crossovers
10/20 Bearish Cross
3 days ago
SELL
Stop Loss Levels
Fixed Risk
1% Risk₹85.81
3% Risk₹84.08
5% Risk₹82.35
7% Risk (Custom)
₹80.61Technical Levels
1x ATR (Volatility)₹82.35
2x ATR (Swing)₹78.02
3x ATR (Trend)₹73.69
Immediate Support₹84.00
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹21.4 Cr | ₹21.9 Cr | ₹26 Cr | ₹28.7 Cr |
| Net Profit | ₹57,80,000 | ₹1.7 Cr | ₹3.3 Cr | ₹4.1 Cr |
| EPS | ₹0.47 | — | ₹2.70 | ₹3.36 |
| Operating Profit | ₹1.7 Cr | ₹3.1 Cr | ₹5.4 Cr | ₹6.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 23 Dec 2024 | Extra Ordinary General Meeting | OTHERS |
| 13 Sept 2024 | Annual General Meeting | AGM |
| 08 Sept 2023 | Annual General Meeting | AGM |
| 01 Sept 2022 | Annual General Meeting | AGM |
| 22 Nov 2021 | Interim Dividend - Rs 1.25 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for PAR
View All
positive
ET Markets - Stocks 5h ago
Vedanta faces buyback costs as bonds trade above par value
In a bold financial maneuver, Vedanta Resources has kicked off a substantial $3.6 billion bond buyback as part of a comprehensive $5.4 billion refinancing endeavor. This strategic decision is designed to lower borrowing expenses and prolong debt maturities. The company is actively in dialogue with investors across the globe to streamline new funding avenues.
GLOBEJMFINANCILPARVALUEVEDLFinancial ServicesHealthcare
positive
Google News - India Markets 1d ago
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSE - Upstox
Stock market rally: Aegis Logistics, Cupid, Akums Drugs, JB Chemicals, among 47 stocks that hit 52-week high on NSEUpstox
AEGISLOGAKUMSCUPIDJGCHEMPARSJLOGISTICChemicalsFast Moving Consumer Goods
negative
Google News - Investing.com India 4d ago
JPMorgan upgrades PAR Technology stock rating after share count error By Investing.com - Investing.com India
JPMorgan upgrades PAR Technology stock rating after share count error By Investing.comInvesting.com India
ARSSBLPARFinancial ServicesHealthcare